Uncategorized

Advancing a New Class of Medicines

Company to Watch – NeuBase Therapeutics In the second of four features on NeuBase Therapeutics, Big4Bio spoke with Founder and CEO Dietrich Stephan and CFO Todd Branning about the company’s precision genetic medicine technology and pipeline, partnering and financing activities, and plans moving forward. By Marie Daghlian Todd Branning, chief financial officer of NeuBase Therapeutics, […]

Read More

Drugging the Genome

Company to Watch – NeuBase Therapeutics In the first of four features on NeuBase Therapeutics, Big4Bio spoke with Founder and CEO Dietrich Stephan and CFO Todd Branning about the spark behind founding of the company, and how it is drugging the genome with precision genetic medicine. The second feature will provide an in-depth focus on […]

Read More

Modelling Biology: A Q&A with Cellarity’s CSO

Company to Watch – Cellarity In the final article in the Company to Watch series on Cellarity, Big4Bio editor Marie Daghlian spoke with Chief Scientific Officer Laurens Kruidenier about what impressed him about the company, what he sees as the strength of the Cellarity platform and how it works, and why we should keep our […]

Read More

A Platform to Uncover Biological Complexity to Target Virtually Any Disease

Company to Watch – Cellarity In the second of four features on Cellarity, Big4Bio spoke with CEO Fabrice Chouraqui about the company’s unique platform, initial pipeline, and plans moving forward. by Marie Daghlian Cellarity aims to discover medicines that can resolve human disease, potentially any disease. To do this it has developed a cell-centric platform […]

Read More

RESI’s First Digital Conference Successful

by Marie Daghlian The global COVID-19 pandemic has changed life as we know it, severely curtailing local and global travel, and postponing or cancelling many conferences and meetings around the world. For the RESI conference organizer Life Science Nation (LSN), however, it has presented an opportunity to go digital, and in fact, after they made […]

Read More

Big3Bio’s Rebranding Brings Big Changes

With the addition of the Greater Philadelphia Area, Big4Bio rounds out its coverage of biopharmaceutical updates from the biggest bioclusters in the world. Here at Big3Bio, the scheduled launch of our brand-new Philadelphia newsletter has kept everyone on their toes. But this June, the much spoken of transformation for Big3Bio will finally come to pass. […]

Read More

Big3Bio and BIO Publish “On Your Mark 2019: The Complete Guide to JPM Week”

BIO CEO Jim Greenwood, Laurie Halloran, CEO of Halloran Consulting, and Tilton Little, Executive Director of Big3Bio, provide the Introduction and Welcomes to this year’s guide SAN FRANCISCO, CA–(December 17, 2018)–Big3Bio, the leading aggregator service for the top biotech hubs in the US—Boston, San Francisco Bay Area, and San Diego—proudly announces the debut of “On […]

Read More

Big3Bio Publishes BIOWeek:Boston 2018, The Complete Guide to the Week of #BIO2018

SAN FRANCISCO, CA–(May 25, 2018)–Big3Bio, the leading aggregator service for the top biotech hubs in the US—Boston, San Francisco Bay Area, and San Diego—proudly announces the first version of BIOWeek:Boston 2018, the compendium of everything going on during the week of the BIO International Convention (#BIO2018), June 3-8. BIOWeek:Boston 2018 not only lists/links all of the major conferences occurring […]

Read More

On Your Mark 2018: The Guide to JPM Week Final Version is Released

On Your Mark 2018: The Guide to JPM Week SAN FRANCISCO, CA–(January 5, 2018)–Big3Bio, the leading aggregator service for the top biotech hubs in the US—Boston, San Francisco Bay Area, and San Diego—proudly announces the final version of On Your Mark 2018, the compendium of everything going on during the week of the J.P. Morgan […]

Read More

Big3Bio Introduces Inaugural Sponsors and Partners of BioWeekSF

Industry leaders to provide thought leadership and more for JPM Week attendees; BIO-BioWeekSF JPM Week webinar and Venture Valuation webinar announced SAN FRANCISCO, Dec. 07, 2017 (GLOBE NEWSWIRE) — Big3Bio is proud to announce the leading industry organizations that have signed on as inaugural partners and sponsors of BioWeekSF, the site dedicated to the J.P. Morgan […]

Read More

BioWeekSF, Big3Bio’s Comprehensive Industry Resource for JPM Week, to Launch in October

Premium-based site launches on October 18th during the BIO Investor Forum; BIO is BioWeekSF’s inaugural “Welcome” Partner SAN FRANCISCO, Sept. 28, 2017 (GLOBE NEWSWIRE) — Big3Bio, the leading aggregator service for the top three life sciences hubs in the US—Boston, San Francisco Bay Area, and San Diego—proudly announces the upcoming launch of BioWeekSF (BioWeekSF.com), a premium […]

Read More